The Indian state, Maharashtra has become the first to fix the price of remdesivir at INR2,360 (US$32.17), which is 16% m...
Roche announced on 13 Oct 2020 that it intends to launch a high-volume SARS-CoV-2 Antigen test as an aid in th...
After encouraging results obtained under named patient use in severe cases of COVID-19, F4 Pharma is now prep...
US-based IQVIA in scientific partnership with the US Food and Drug Administration (FDA), will provide agile analytics fr...
Taiwan based TTY Biopharm Company, has announced that it has received authorization for the delivery of coronavirus vacc...
Honeywell has recently launched an integrated set of solutions in Malaysia to help building owners improve the...
US based Eli Lilly and Company and Incyte shared additional data showing baricitinib in combination with remdesivir...
A joint Korean research team comprised of Professor Jeong Wook Lee and Ph.D. candidate Chang Ha Woo and Professor Gyoo Y...
A further collaboration among the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volu...
Johnson & Johnson on 8 Oct 2020 announced that the European Commission (EC), acting on behalf of the Europea...
With the increase in COVID-19 cases in most countries of WHO South-East Asia Region, World Health Organization has calle...
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway has announced partnerships with five clinical sampl...
The Australian Government is investing a total of $2.3 billion to support home-grown researchers and manufacturers to de...
Amuse Group Holding Limited and Grand View Bio Tech announced the establishment of their joint venture GENE Life Company...
New Zealand-based Ubiquitome is ramping up production of its mobile, real-time (RT) PCR technology with fundin...
Royal Philips, a global leader in health technology, has announced findings from its study of 15 countries, the Future H...
Japan's Eisai has entered into a joint research agreement with four research organizations (KAN Research Institute, Nati...
TaiGen Biotechnology Company, Limited ("TaiGen") announced on 5 Oct 2020 that it has filed an Investigational New Drug (...
